NDC11 45963030309
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 45963-0303-09 | 45963-0303 |
| 45963-0303-9 | 45963-0303 |
| 45963-303-09 | 45963-303 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| dextroamphetamine sulfate | DEXTROAMPHETAMINE SULFATE | Actavis Pharma, Inc. | 9e92ccc3-d81c-461d-a19f-7e9b582be357 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 45963-303-09 45963-303 45963030309 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.